Roche to launch SARS-CoV-2 and flu A/B Rapid Antigen Test in countries accepting the CE mark
The combination rapid antigen test quickly differentiates between SARS-CoV-2 and influenza viruses A and B infections, with results ready in less than 30 minutes, allowing informed decisions on patient and pandemic management decisions